Prevalence of multiple sclerosis in Bogotá, Colombia

Neuroepidemiology

Volumn 28, Issue 1, 2007, Pages 33-38

  Toro, Jaime ^a,b,c   Sarmiento, Olga L ^a   Díaz Del Castillo, Adriana ^a   Satizábal, Claudia Liliana ^a   Ramírez, Jhon Darwin ^a,b   Montenegro, Ana Cristina ^a,b   Góngora, María Carolina ^a   Quiñones, Jairo Alonso ^a,b   Díaz, Andrés ^a,b   Tobón, Alejandro ^a,b  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

^c Asociacion Medica de Los Andes   (Colombia)

Author keywords

Multiple sclerosis; Prevalence, multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; POPULATION RISK; PREVALENCE; RELIABILITY; REVIEW; SAMPLE SIZE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COLOMBIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; RISK ASSESSMENT; SEX DISTRIBUTION; URBAN HEALTH;

EID: 33846869050     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097854     Document Type: Review

References (31)

1. Kurtzke JF: A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 1975;51:137-157.
2. Pugliatti M, Sotgiu S, Rosati G: The world-wide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-191.
3. Rosati G: The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117-139.
4. Hernandez-Valero E, Cabrera-Gomez JA, Valenzuela C: Clinical features of multiple sclerosis in western Cuba. A comparison with two other regions in the country (in Spanish). Rev Neurol 2004;38:818-823.
5. Callegaro D, de Lolio CA, Radvany J, Tilbery CP, Mendonca RA, Melo AC: Prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, in 1990. Neuroepidemiology 1992;11:11-14.
6. Callegaro D, Goldbaum M, Morais L, Tilbery CP, Moreira MA, Gabbai AA, Scaff M: The prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, 1997. Acta Neurol Scand 2001;104:208-213.
7. Aguilar Rebolledo F, Estanol Vidal B, del Angel Torres A, Cabanas Garcia A, Lopes Rios G, Benitez L: Multiple sclerosis: clinical, paraclinical study and management of 24 cases (in Spanish). Rev Invest Clin 1985;37:231-235.
8. Sanchez JL, Aguirre C, Arcos-Burgos OM, Jimenez I JM, Leon F, Pareja J, Pradilla G, Uribe B, Uribe CS, Villa A, Volcy M, Palacio LG: Prevalence of multiple sclerosis in Colombia (in Spanish). Rev Neurol 2000;31:1101-1103.
9. http://www.saludcapital.gov.co/secsalud/estadisticas (November 21, 2005).
10. Castaño RA, Arbelaez JJ, Giedion UB, Morales LG: Equitable financing, out-of-pocket payments and the role of health care reform in Colombia. Health Policy Plan 2002;17:5-11.
11. http://www.bogota-dc.com/history/boghis.htm (November 21, 2005).
12. http://www.dane.gov.co/index.php?option=com_content&task= category§ionid=23&id=185&Itemid=383# (March 6, 2006).
13. Mckeown A: Global migration, 1846-1940. J World History 2004;15:155-189.
14. htpp://www.faculty.econ.nortwestern.edu/faculty/bernal/Health and Race june 22.pdf (February 2, 2006).
15. McDonald WI, Compston A, Edan G, Gookin D, Hartung H, Lublin F, McFarland H, Paty D, Polman C, Reingold S, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker B, Wolinsky J: Recommended diagnostic criteria for multiple sclerosis: guideliness from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
16. Poser CM, Brinar VV: The nature of multiple sclerosis. Clin Neurol Neurosurg 2004;106:159-171.
17. Cytel Software Corporation: StatXact Manual Version 7.0. Cambridge, Cytel Software, 2005.
18. Banks J, Carson J, Nelson B, Nicol D: Discrete-Event System Simulation, ed 3. Engelwood Cliffs, Prentice Hall, 2001.
19. SAS Institute Inc: SAS/STAT User's Guide Version 8.2, ed 4. Cary, SAS Institute, 2000.
20. http://www.minproteccionsocial.gov.co/MseContent/NewsDetail.asp?ID= 13482& IDCompany=24 (January 3, 2006).
21. Kurtzke JF: A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand 1975;51:110-136.
22. McDonnell GV, Hawkins SA: An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1998;50:423-428.
23. Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R: Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 2004;109:378-384.
24. Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
25. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000;343:938-952.
26. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M: Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003;61:1373-1377.
27. Ruggieri M, Ianetti P, Polizzi A, Pavone L, Grimaldi LME: Multiple sclerosis in children under 10 years of age. Neurol Sci 2004;25:S326-S335.
28. Christensen J: Multiple sclerosis: some epidemiological clues to its etiology. Acta Neurol Latinoamer 1975;21:66-85.
29. Grainger R, Allison D, Adam A, Dixon A: Magnetic resonance imaging: basic principles; in Grainger R, Allison D, Adam A, Dixon A, Carty H, Sprig A (eds): Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging. Edinburgh, Churchill Livingstone, 2001, pp 101-136.
30. Kurtzke JF: Epidemiology and multiple sclerosis. Rev Neurol 2002;35:1177.
31. http://www.minproteccionsocial.gov.co/MseContent/NewsDetail.asp?ID= 13482&IDCompany=24 (February 7, 2006).